K. Swaminathan, J. Davies, J. George, et al. Spironolactone for poorly controlled hypertension in type 2 diabetes: Conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles. Diabetologia, 2008, 51(5): 762-768.